These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29844844)

  • 1. Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study.
    Kisch AM; Forsberg A
    Open Nurs J; 2018; 12():46-57. PubMed ID: 29844844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Having a sibling as donor: patients' experiences immediately before allogeneic hematopoietic stem cell transplantation.
    Kisch A; Bolmsjö I; Lenhoff S; Bengtsson M
    Eur J Oncol Nurs; 2014 Aug; 18(4):436-42. PubMed ID: 24721180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Core of Sibling Stem Cell Donation - A Grounded Theory Study.
    Kisch AM; Forsberg A
    Open Nurs J; 2017; 11():73-83. PubMed ID: 28839511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Being a haematopoietic stem cell donor for a sick sibling: Adult donors' experiences prior to donation.
    Kisch A; Bolmsjö I; Lenhoff S; Bengtsson M
    Eur J Oncol Nurs; 2015 Oct; 19(5):529-35. PubMed ID: 25813531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of adults with sickle cell disease and their HLA-matched adult sibling donors after allogeneic hematopoietic stem cell transplantation.
    Gallo AM; Patil CL; Knafl KA; Angst DA; Rondelli D; Saraf SL
    J Adv Nurs; 2019 Nov; 75(11):2943-2951. PubMed ID: 31287187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant.
    McIver Z; Melenhorst JJ; Wu C; Grim A; Ito S; Cho I; Hensel N; Battiwalla M; Barrett AJ
    Haematologica; 2013 Mar; 98(3):346-52. PubMed ID: 23065508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
    Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better the donor you know? A qualitative study of renal patients' views on 'altruistic' live-donor kidney transplantation.
    Bailey PK; Ben-Shlomo Y; de Salis I; Tomson C; Owen-Smith A
    Soc Sci Med; 2016 Feb; 150():104-11. PubMed ID: 26745864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health transition after lung transplantation - a grounded theory study.
    Lundmark M; Erlandsson LK; Lennerling A; Almgren M; Forsberg A
    J Clin Nurs; 2016 Aug; 25(15-16):2285-94. PubMed ID: 27230156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
    Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
    Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients.
    Cho BS; Yahng SA; Min GJ; Park S; Park SS; Shin SH; Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
    Transplant Cell Ther; 2021 Sep; 27(9):774.e1-774.e12. PubMed ID: 34082159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.